- Home
- ACVA vs CERT Comparison
ACVA vs CERT Comparison
Compare ACVA & CERT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ACVA | CERT |
|---|---|---|
| Founded | 2014 | 2008 |
| Country | United States | United States |
| Employees | 3200 | N/A |
| Industry | Business Services | Retail: Computer Software & Peripheral Equipment |
| Sector | Consumer Discretionary | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 860.9M |
| IPO Year | 2021 | 2020 |
Fundamental Metrics
Financial Performance| Metric | ACVA | CERT |
|---|---|---|
| Price | $5.90 | $5.12 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 12 | 10 |
| Target Price | $11.32 | ★ $11.67 |
| AVG Volume (30 Days) | ★ 3.7M | 3.1M |
| Earning Date | 05-06-2026 | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 18.75 | ★ 87.50 |
| EPS | N/A | N/A |
| Revenue | ★ $759,606,000.00 | $418,838,000.00 |
| Revenue This Year | $14.01 | $4.18 |
| Revenue Next Year | $12.62 | $5.39 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 19.22 | 8.75 |
| 52 Week Low | $4.07 | $4.45 |
| 52 Week High | $17.16 | $13.88 |
Technical Indicators
Market Signals| Indicator | ACVA | CERT |
|---|---|---|
| Relative Strength Index (RSI) | 57.78 | 43.05 |
| Support Level | $4.86 | N/A |
| Resistance Level | $8.37 | $6.47 |
| Average True Range (ATR) | 0.38 | 0.35 |
| MACD | 0.00 | -0.08 |
| Stochastic Oscillator | 53.59 | 35.66 |
Price Performance
Historical ComparisonAbout ACVA ACV Auctions Inc.
ACV Auctions Inc operates a mobile platform for wholesale car auctions. It provides a digital marketplace for wholesale vehicle transactions and data services that offer transparent and accurate vehicle information for customers. Additionally, the company's marketplace platform is supported by remarketing centers in various locations throughout the United States.
About CERT Certara Inc.
Certara Inc accelerates medicines to patients using biosimulation software and technology to transform traditional drug discovery and development. It provides modeling and simulation, regulatory science, and assessment software and services to help clients reduce clinical trials, accelerate regulatory approval, and increase patient access to medicines. The company has its business presence in the Americas, which is also its key revenue-generating market, EMEA, and the Asia Pacific region.